News

One-time therapy may be ‘transformative option’ for treating deadly skin cancer
Almost one in five patients with advanced melanoma survived for five years after receiving lifileucel, a trial has found.
‘Transformative’ one-time therapy could help skin cancer patients live longer
Almost one in five patients with advanced melanoma survived for five years after receiving the innovative treatment ...